Three-dimensional optoacoustic imaging as a new noninvasive technique to study long-term biodistribution of optical contrast agents in small animal models

Journal of Biomedical Optics

Volumn 17, Issue 10, 2012, Pages

  Su, Richard ^a,b   Ermilov, Sergey A ^a   Liopo, Anton V ^a   Oraevskya, Alexander A ^a,b  

^a TomoWave Laboratories   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

Functional imaging; Nude mice; Optoacoustic tomography; PEGylated gold nanorods; Three dimensional imaging

Indexed keywords

CONTRAST MEDIUM; GOLD; NANOTUBE;

ANIMAL; ARTICLE; CHEMISTRY; FLUORESCENCE IMAGING; METHODOLOGY; MOUSE; NUDE MOUSE; PHOTOACOUSTICS; THREE DIMENSIONAL IMAGING; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

ANIMALS; CONTRAST MEDIA; GOLD; IMAGING, THREE-DIMENSIONAL; MICE; MICE, NUDE; NANOTUBES; OPTICAL IMAGING; PHOTOACOUSTIC TECHNIQUES; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

EID: 84876523479     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.17.10.101506     Document Type: Article

References (55)

1. V. P. Torchilin, PEG-based micelles as carriers of contrast agents for different imaging modalities, Adv. Drug Delivery Rev. 54(2), 235-252 (2002). (Pubitemid 34230444)
2. S. Y. Shim, D. K. Lim, and J. M. Nam, Ultrasensitive optical biodiagnostic methods using metallic nanoparticles, Nanomedicine 3(2), 215-232 (2008).
3. L. Tong et al., Gold nanorods as contrast agents for biological imaging: Optical properties, surface conjugation and photothermal effects, Photochem. Photobiol. 85(1), 21-32 (2009).
4. S. Manohar, C. Ungureanu, and T. G. Van Leeuwen, Gold nanorods as molecular contrast agents in photoacoustic imaging: The promises and the caveats, Contrast Media Mole. Imag. 6(5), 389-400 (2011).
5. A. M. Alkilany and C. J. Murphy, Toxicity and cellular uptake of gold nanoparticles: What we have learned so far, J. Nanopart. Res. 12(7), 2313-2333 (2010).
6. E. C. Dreaden et al., Beating cancer in multiple ways using nanogold, Chem. Soc. Rev. 40(7), 3391-3404 (2011).
7. A. Kopwitthaya et al., Biocompatible PEGylated gold nanorods as colored contrast agents for targeted in vivo cancer applications, Nanotechnology 21(31), 315101 (2010).
8. J. V. Jokerst et al., Nanoparticle PEGylation for imaging and therapy, Nanomedicine 6(4), 715-728 (2011).
9. W. S. Cho et al., Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles, Toxicol. Appl. Pharm. 236(1), 16-24 (2009).
10. H. F. Zhang et al., Functional photoacoustic microscopy for highresolution and noninvasive in vivo imaging, Nat. Biotech. 24(7), 848-851 (2006). (Pubitemid 44086627)
11. A. Oraevsky, Gold and silver nanoparticles as contrast agents for optoacoustic imaging, in Photoacoustic Imaging and Spectroscopy, L. Wang, Ed., Taylor and Francis Group, New York (2009).
12. S. A. Ermilov et al., Laser optoacoustic imaging system for detection of breast cancer, J. Biomed. Opt. 14(2), 024007 (2009).
13. J. Hu et al., In vivo photoacoustic imaging of osteosarcoma in a rat model, J. Biomed. Opt. 16(2), 020503 (2011).
14. S. Mallidi et al., Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer, Nano Lett. 9(8), 2825-2831 (2009).
15. T. Sun and G. J. Diebold, Generation of ultrasonic waves from a layered photoacoustic source, Nature 355(6363), 806-808 (1992).
16. A. A. Oraevsky and A. A. Karabutov, Optoacoustic tomography, in T. Vo-Dinh, Ed., Biomedical Photonics Handbook, pp. 34/31-34/34, CRC Press, Boca Raton (2003).
17. J. Yao and L. V. Wang, Photoacoustic tomography: Fundamentals, advances and prospects, Contrast Media Mole. Imag. 6(5), 332-345 (2011).
18. X. Wang et al., Noninvasive laser-induced photoacoustic tomography for structural and functional in vivo imaging of the brain, Nat. Biotech. 21(7), 803-806 (2003). (Pubitemid 36791400)
19. H. P. Brecht et al., Whole-body three-dimensional optoacoustic tomography system for small animals, J. Biomed. Opt. 14(6), 064007 (2009).
20. R. Su et al., Gold nanorod distribution in mouse tissues after intravenous injection monitored with optoacoustic tomography, Proc. SPIE 7899, 78994B (2011).
21. A. De La Zerda et al., Advanced contrast nanoagents for photoacoustic molecular imaging, cytometry, blood test and photothermal theranostics, Contrast Media Mole. Imag. 6(5), 346-369 (2011).
22. R. X. Xu, Multifunctional microbubbles and nanobubbles for photoacoustic imaging, Contrast Media Mole. Imag. 6(5), 401-411 (2011).
23. J. A. Copland et al., Bioconjugated gold nanoparticles as a molecular based contrast agent: Implications for imaging of deep tumors using optoacoustic tomography, Mole. Imag. Biol. 6(5), 341-349 (2004).
24. W. Li et al., Gold nanocages as contrast agents for photoacoustic imaging, Contrast Media Mole. Imag. 6(5), 370-377 (2011).
25. D. Pan et al., Recent advances in colloidal gold nanobeacons for molecular photoacoustic imaging, Contrast Media Mole. Imag. 6(5), 378-388 (2011).
26. X. Huang et al., Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods, J. Am. Chem. Soc. 128(6), 2115-2120 (2006). (Pubitemid 43277351)
27. P. M. Tiwari et al., Functionalized gold nanoparticles and their biomedical applications, Nanomaterials 1(1), 31-63 (2011).
28. H. Liao and J. H. Hafner, Gold nanorod bioconjugates, Chem. Mater. 17(18), 4636-4641 (2005). (Pubitemid 41362493)
29. D. P. Lankveld et al., Blood clearance and tissue distribution of PEGylated and non-PEGylated gold nanorods after intravenous administration in rats, Nanomedicine 6(2), 339-349 (2011).
30. M. Eghtedari et al., High sensitivity of in vivo detection of gold nanorods using a laser optoacoustic imaging system, Nano Lett. 7(7), 1914-1918 (2007). (Pubitemid 47197566)
31. C. K. Liao et al., Nanorod-based flow estimation using a high-framerate photoacoustic imaging system, J. Biomed. Opt. 12(6), 064006 (2007).
32. X. Huang et al., Applications of gold nanorods for cancer imaging and photothermal therapy, Methods Mol. Biol. 624(1), 343-357 (2010).
33. D. L. Chamberland et al., Photoacoustic tomography of joints aided by an etanercept-conjugated gold nanoparticle contrast agent-an ex vivo preliminary rat study, Nanotechnology 19(9), 095101 (2008).
34. R. Su et al., Optoacoustic tomography in preclinical research: In vivo distribution of highly purified PEG-coated gold nanorods, Proc. SPIE 8089, 808902 (2011).
35. S. A. Ermilov et al., Data processing and quasi-3D optoacoustic imaging of tumors in the breast using a linear arc-shaped array of ultrasonic transducers, Proc. SPIE 6856, 685603 (2008).
36. M. E. Wall, A. Rechtsteiner, and L. M. Rocha, Singular value decomposition and principal component analysis, in A Practical Approach to Microarray Data Analysis, D. P. Berrar,W. Dubitzky, and M. Granzow, Eds., , pp. 91-109, Kluwer, Norwell MA (2003). http://public.lanl.gov/mewall/kluwer2002.html
37. A. V. Liopo et al., Photothermal therapy of acute leukemia cells in the near-infrared region using gold nanorods CD-33 conjugates, Proc. SPIE 7897, 789710 (2011).
38. T. K. Sau and C. J. Murphy, Seeded high yield synthesis of short Au nanorods in aqueous solution, Langmuir 20(15), 6414-6420 (2004).
39. T. Niidome et al., PEG-modified gold nanorods with a stealth character for in vivo applications, J. Ctrl. Rel. 114(3), 343-347 (2006). (Pubitemid 44310822)
40. A. B. Criado et al., Reduction of isoflurane MAC with buprenorphine and morphine in rats, Lab. Animals 34(3), 252-259 (2000). (Pubitemid 30456219)
41. C. Constantinides, R. Mean, and B. J. Janssen, Effects of isoflurane anesthesia on the cardiovascular function of the C57BL/6 mouse, ILAR J. 52(2), e21-e31 (2011).
42. M. Eghtedari et al., Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells, Nano Lett. 9(1), 287-291 (2009).
43. Y. S. Chen et al., Enhanced thermal stability of silica-coated gold nanorods for photoacoustic imaging and image-guided therapy, Opt. Express 18(9), 8867-8878 (2010).
44. D. Mirska et al., Biophysical and biochemical properties of a binary lipid mixture for DNA transfection, Colloids Surf. 40(1), 51-59 (2005). (Pubitemid 40028310)
45. B. C. Rostro-Kohanloo et al., The stabilization and targeting of surfactant-synthesized gold nanorods, Nanotechnology 20(43), 434005 (2009).
46. G. Von Maltzahn et al., Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas, Cancer Res. 69(9), 3892-3900 (2009).
47. T. B. Huff et al., Controlling the cellular uptake of gold nanorods, Langmuir 23(4), 1596-1599 (2007). (Pubitemid 46406099)
48. J. Lipka et al., Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection, Biomaterials 31(25), 6574-6581 (2010).
49. M. Arnida et al., Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages, Eur. J. Pharm. Biopharm. 77(3), 417-423 (2011).
50. C. H. Choi et al., Targeting kidney mesangium by nanoparticles of defined size, Proc. Natl. Acad. Sci. USA 108(16), 6656-6661 (2011).
51. L. Kou, D. Labrie, and P. Chylek, Refractive indices of water and ice in the 0.65-to 2.5-microm spectral range, Appl. Opt. 32(19), 3531-3540 (1993).
52. A. Roggan et al., Optical properties of circulating human blood in the wavelength range 400-2500, J. Biomed. Opt. 4(1), 36-46 (1999). (Pubitemid 129694550)
53. ANSI, American National Standard for Safe Use of Lasers, American National Standards Institutes Z136.1, 6-24 (2007).
54. M. R. Hamblin and T. N. Demidova, Mechanisms of low-light therapy, Proc. SPIE 6140, 614001 (2006).
55. S. Wray et al., Characterization of the near infrared absorption spectra of cytochrome aa3 and haemoglobin for the non-invasive monitoring of cerebral oxygenation, Biochim. Biophys. Acta 933(1), 184-192 (1988). (Pubitemid 18086628)